PREVALENCE OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTION AMONG WOMEN ATTENDING VINMEC TIMES CITY INTERNATIONAL GENERAL HOSPITAL

Vu Duy Thai1, Nguyen Thi Thu Ha1, Do Minh Huong1, Ha Thi Tuyet Mai1, Phi Thi Minh Phuong1, Tran Thi Bich Phuong1, Doan Thi Lai1, Nguyen Thi Nhung1, Tran Thi Thu Ha1, Luong Thi Tam1, Luong Thanh Trung2, Pham Ba Nha1, Nguyen Thi Thu Thai3, Nguyen Thi Hien3
1 Vinmec Times City International General Hospital
2 International Medical Quarantine Center of Hai Phong
3 University of Medicine and Pharmacy, Thai Nguyen University

Main Article Content

Abstract

Objective: To describe the prevalence and characteristics of high-risk HPV infection among women attending Vinmec Times City International General Hospital.


Research methods: A cross-sectional study was conducted on 381 women who underwent concurrent high-risk HPV DNA testing and cervical cytology screening at Vinmec Times City International General Hospital from August 2024 to March 2025.


Results: The mean age of participants was 44.6 ± 12.5 years. The mean age at menarche and menopause were 11.7 ± 0.7 years and 49.9 ± 0.8 years, respectively. Nearly half of the participants (49.1%) had a history of gynecological disease treatment. The overall HPV prevalence was 13.6%. Among HPV-positive cases, HPV type 16 accounted for 7.7%, type 18 for 11.5%, other 12 high-risk types for 65.4%, and multiple infections for 15.4%. Women with cervical lesions were 2.1 times more likely to have high-risk HPV infection than those without lesions (OR = 2.1; 95% CI: 1.1-4.0; p < 0.05).


Conclusion: The prevalence of high-risk HPV infection among women attending Vinmec Times City International General Hospital was 13.6%, with types 18, 16, and other high-risk genotypes predominating. HPV infection was significantly associated with cervical lesions, emphasizing the critical role of HPV in cervical pathology and the importance of routine screening and HPV vaccination for effective cervical cancer prevention.

Article Details

References

[1] Hyuna Sung et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2021, 71 (3): 209-249. 10.3322/caac.21660.
[2] Bruni L. ICO/IARC HPV Information Centre: HPV and related diseases in Vietnam, 2023.
[3] Muñoz N et al. Epidemiologic classification of human Papillomavirus types associated with cervical cancer. New England Journal of Medicine, 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.
[4] Nguyễn Tiến Quang, Nguyễn Thị Bích Phương. Đặc điểm nhiễm HPV nguy cơ cao ở các tổn thương bất thường cổ tử cung và ung thư cổ tử cung tại Bệnh viện K. Tạp chí Y học Việt Nam, 2021, 509 (2): 257-260. https://doi.org/10.51298/vmj.v509i2.1841.
[5] Nguyễn Thị Huy và cộng sự. Tình trạng nhiễm HPV nguy cơ cao và mối liên quan với tổn thương tế bào học cổ tử cung ở phụ nữ đến khám phụ khoa tại Bệnh viện Vinmec Times City năm 2022-2023, Tạp chí Y học Việt Nam, 2024, 542 (3): 241-245.https://doi.org/10.51298/vmj.v542i3.11216.
[6] Nguyễn Duy Ánh (2022), Nghiên cứu tỷ lệ mắc HPV và một số yếu tố liên quan ở phụ nữ trong độ tuổi sinh sản ở Hà Nội, Tạp chí Y học Việt Nam, vol. 512, no. 1. https://doi.org/10.51298/vmj.v512i1.2218.
[7] Lin C et al. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. The Lancet Infectious Diseases, 2018, 18 (2): 198-206. 10.1016/S1473-3099(17)30653-9.
[8] Bao Y.P et al. Human Papillomavirus type distribution in women from Asia: a meta-analysis. International Journal of Gynecological Cancer, 2008,18 (1): 71-79. 10.1111/j.1525-1438.2007.00959.x.
[9] Plummer M et al. Multiple human Papillomavirus infections: the exception or the rule? Infectious Diseases Society of America, 2011, 203 (7): 891-893. 10.1093/infdis/jir038.
[10] Walboomers J.M et al. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology, 1999, vol. 189 (1): 12-19. 10.1002/
( S I C I ) 1 0 9 6 - 9 8 9 6 ( 1 9 9 9 0 9 ) 1 8 9 : 1 < 1 2 : : A I D -PATH431>3.0.CO;2-U.
[11] Castellsagué X et al. Environmental co-factors in HPV carcinogenesis. Virus Research, 2002, 89 (2): 191-199. 10.1016/S0168-1702(02)00169-0.